Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Perioperative intravenous ketamine for acute postoperative pain in adults

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD012033.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 20 septiembre 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Dolor y cuidados paliativos

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Elina CV Brinck

    Correspondencia a: Department of Anesthesiology, Intensive Care and Pain Medicine, Division of Anesthesiology, Töölö Hospital, Helsinki University and Helsinki University Hospital, Helsinki, Finland

    [email protected]

  • Elina Tiippana

    Department of Anesthesiology, Intensive Care and Pain Medicine, Division of Anesthesiology, Hyvinkää Hospital, Helsinki University and Helsinki University Hospital, Helsinki, Finland

  • Michael Heesen

    Department of Anaesthesia and Intensive Care, Kantonsspital Baden, Baden, Switzerland

  • Rae F Bell

    Regional Centre of Excellence in Palliative Care, Haukeland University Hospital, Bergen, Norway

  • Sebastian Straube

    Department of Medicine, Division of Preventive Medicine, University of Alberta, Edmonton, Canada

  • Vesa Kontinen

    Department of Anesthesiology, Intensive Care and Pain Medicine, Division of Anesthesiology, Jorvi Hospital, Helsinki University and Helsinki University Hospital, Helsinki, Finland

Contributions of authors

ECVB and VKK developed the search strategy, ECVB wrote and VKK revised the background section, ECVB and ET will be responsible for the data extraction, and ECVB, ET and VKK will be responsible for the data analysis. RFB is the lead author of the previous Cochrane review on this topic. All authors will be responsible for completing the protocol, full review and updating the review in future.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • State funding for university‐level health research (grant TYH2014305), Finland.

Declarations of interest

ECVB has no known conflicts of interest to declare that are relevant to the development of this protocol. For transparency, ECVB has received a lecture fee from the pharmaceutical company Orion, but it is not related to this review protocol. This pharmaceutical company does not have any interest in ketamine, nor has it funded this review.

ET has no known conflicts of interest to declare that are relevant to the development of this protocol.

MH has no known conflicts of interest to declare that are relevant to the development of this protocol.

RFB has no conflicts relating to this review protocol or any similar product. For transparency, RFB was a member of the Editorial Board of a Pfizer Norwegian publication 'Smertefokus' ('Pain Focus') until 31 January 2013. Pfizer manufactures ketamine.

SS has no conflicts relating to this review protocol or any similar product. For transparency, SS has received research support and honoraria from charities, government and commercial sources at various times, but none relate to this review protocol.

VKK has no conflicts relating to this review protocol or any similar product. For transparency, VKK has received research support from government, and has received lecture fees from events organised or supported by the pharmaceutical industry but none relate to this review protocol. Grünenthal, Janssen‐Cilag, MSD, Mundipharma, Orion and Steripolar do not produce or have any specific interest in ketamine. Pfizer manufactures ketamine. These companies have not funded this review.

Acknowledgements

This review has been supported financially in part by Finnish state funding for university‐level health research (grant TYH2014305).

Kerry Harding and Anna Erskine at the Cochrane Pain, Palliative and Supportive Care review group (PaPaS), Oxford, UK, gave valuable input in the revising process.

Joanne Abbott (PaPaS Cochrane group) assisted with the database searches.

We would like to thank Daryl I Smith, Andrew D Farmery, Alimi Mustapha and Peter Cole (peer reviewers) for their valuable comments in the preparation of this protocol.

Cochrane Review Group funding acknowledgement: The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane PaPaS Group. Disclaimer: The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, National Health Service (NHS) or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2018 Dec 20

Perioperative intravenous ketamine for acute postoperative pain in adults

Review

Elina CV Brinck, Elina Tiippana, Michael Heesen, Rae Frances Bell, Sebastian Straube, R Andrew Moore, Vesa Kontinen

https://doi.org/10.1002/14651858.CD012033.pub4

2017 Sep 20

Perioperative intravenous ketamine for acute postoperative pain in adults

Protocol

Elina CV Brinck, Elina Tiippana, Michael Heesen, Rae F Bell, Sebastian Straube, Vesa Kontinen

https://doi.org/10.1002/14651858.CD012033.pub3

2017 Jun 14

Perioperative intravenous ketamine for acute postoperative pain in adults

Protocol

Elina CV Brinck, Elina Tiippana, Michael Heesen, Rae F Bell, Sebastian Straube, Vesa Kontinen

https://doi.org/10.1002/14651858.CD012033.pub2

2016 Jan 07

Perioperative intravenous ketamine for acute postoperative pain in adults

Protocol

Elina CV Brinck, Elina Tiippana, Michael Heesen, Rae F Bell, Sebastian Straube, Vesa Kontinen

https://doi.org/10.1002/14651858.CD012033

Notes

June 2017: This protocol has been withdrawn due to the full review not meeting the standards of quality and timeliness expected by Cochrane and the PaPaS review group.

September 2017: Following discussions with the authors and editors, this protocol has been reinstated. A new author has been added to the author team who will act as guarantor to ensure the full review meets current standards and expectations.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.